Philips receives FDA premarket approval for its HeartStart OnSite and HeartStart Home defibrillators
Amsterdam, the Netherlands –Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the Center for Devices and Radiological Health (CDRH) of the Food and Drug ...
WASHINGTON – Federal health regulators are warning the public that certain cardiac defibrillators recalled by Philips Healthcare may fail to deliver a needed shock in an emergency. Defibrillators are ...
The Philips HeartStart OnSite Defibrillator is designed to be the easiest-to-use, and most reliable defibrillator available. Available without a prescription from ActiveForever.com, the Philips ...
Philips recalled its HeartStart MRx Defibrillator due to an equipment defect, according to a Feb. 9 safety notice from the FDA. Here are three things to know. 1. Philips initiated the recall in June ...
Royal Philips, a global leader in health technology, announced that the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) has approved the company’s premarket ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results